Yüklüyor......

Targeted Gene Modification of Hematopoietic Progenitor Cells in Mice Following Systemic Administration of a PNA-peptide Conjugate

Hematopoietic stem cell (HSC) gene therapy offers promise for the development of new treatments for a variety of hematologic disorders. However, efficient in vivo modification of HSCs has proved challenging, thus imposing constraints on the therapeutic potential of this approach. Herein, we provide...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Rogers, Faye A, Lin, Sharon S, Hegan, Denise C, Krause, Diane S, Glazer, Peter M
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: Nature Publishing Group 2012
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3255600/
https://ncbi.nlm.nih.gov/pubmed/21829173
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/mt.2011.163
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!